The Protective Effect of Theaflavins on the Kidney of Mice with Type II Diabetes Mellitus

Jun Wang,Jingjing Jiang,Changyu Zhao,Hongyan Shan,Ziheng Shao,Chun Wang,Jiayun Guan,Zhongwen Xie,Songnan Li
DOI: https://doi.org/10.3390/nu15010201
IF: 5.9
2023-01-01
Nutrients
Abstract:Diabetic nephropathy, primarily caused by advanced glycation end products (AGEs), is a serious complication resulting from type 2 diabetes mellitus (T2DM). Reportedly, theaflavins (TFs) can improve diabetic nephropathy; however, the underlying molecular mechanism is not fully clear. In this study, T2DM mice were treated with different concentrations of TFs by gavage for 10 weeks to investigate the effect of TFs on diabetic nephropathy and their potential molecular mechanism of action. Biochemical and pathological analysis showed that the TFs effectively improved blood glucose, insulin resistance, kidney function, and other symptoms in diabetic mice. The mechanism studies indicated that TFs inhibited the formation of AGEs, thereby inhibiting the activation of the MAPK/NF-κB signaling pathway. Therefore, our study suggested that TFs improved diabetic nephropathy by inhibiting the formation of AGEs.
nutrition & dietetics
What problem does this paper attempt to address?